Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > NanoString Technologies Obtains CE Mark for PAM50-based Test for Breast Cancer: Testing Kit Available in Early 2013 Will Offer EU Patients Risk of Recurrence Score and Intrinsic Subtyping

Abstract:
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced it has obtained the CE Mark for its PAM50-based gene expression test for breast cancer, clearing the company to sell its test in the European Union and other countries recognizing the CE Mark.

NanoString Technologies Obtains CE Mark for PAM50-based Test for Breast Cancer: Testing Kit Available in Early 2013 Will Offer EU Patients Risk of Recurrence Score and Intrinsic Subtyping

Seattle, WA | Posted on September 27th, 2012

NanoString's test provides a subtype classification based on the fundamental biology of an individual's breast tumor (referred to as intrinsic subtyping), as well as a prognostic score that predicts the probability of cancer recurrence over 10 years in post-menopausal women with hormone receptor-positive, early stage breast cancer (ESBC) who have been treated with hormonal therapy. Together with studies from the literature, this information has been shown to convey valuable information about a patient's prognosis that can inform critical decisions about the patient's course of therapy.

"We are delighted to complete our first regulatory filing for our PAM50-based gene expression diagnostic test for breast cancer less than two years after beginning our rigorous clinical development program," said Bruce Seeley, Senior Vice President & General Manager, Diagnostics at NanoString Technologies. "Women and their clinicians in countries that accept the CE Mark will soon have a new option for informing important treatment decisions, and for bringing more certainty to those decisions. This filing is right on the heels of the landmark study from The Cancer Genome Atlas that demonstrated the power of the PAM50 for subtyping breast cancer into four distinct diseases, and importantly the clinical use of intrinsic subtyping is already included in the St. Gallen International Breast Cancer Treatment Guidelines."

NanoString intends to begin marketing its breast cancer test in major markets that accept the CE Mark in early 2013. The company has a worldwide license for the PAM50 gene signature to develop in vitro diagnostic and research products for breast cancer on its nCounter® Analysis System. The clinical development program for NanoString's PAM50-based breast cancer test is designed to support both regulatory requirements for market-specific approval and its incorporation into worldwide breast cancer treatment guidelines.

"PAM50 on the nCounter platform represents the next generation in genomic testing for breast cancer, providing a powerful new tool for reliable and accurate genomic testing that can be done in local laboratories in countries that recognize the CE Mark," said Brad Gray, President and Chief Executive Officer of NanoString Technologies. "This regulatory filing is an important milestone in NanoString's vision to support the global democratization of genomic testing, and make high-impact gene-profiling tests widely available as in vitro diagnostic products. We extend heart-felt congratulations and gratitude to our collaborators who contributed to this achievement."

The CE Mark is based on positive results from NanoString's first clinical validation study, as well as a recently completed multi-site analytical validation study. The results of the clinical validation study, which included more than 1,000 samples from the TransATAC study of postmenopausal women with hormone receptor-positive early-stage breast cancer (ESBC), were presented by the study's independent investigators at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The results of the multi-site analytical validation study are expected to be presented at a major clinical meeting during 2013.

The test that is the subject of the CE Mark is available in the United States as Investigational Use Only. The test runs on the nCounter system, which is presently offered in the United States as Research Use Only, and is not intended for diagnostic use in the United States.

####

About NanoString Technologies, Inc.
NanoString Technologies is a privately held provider of life science tools for translational research and developer of molecular diagnostics. The company’s nCounter Analysis System is the first and only technology platform to deliver highly multiplexed, direct profiling of individual molecules in a single reaction without amplification. The nCounter Analysis System offers a cost-effective way to easily profile hundreds of gene transcripts, copy number variations, or miRNAs simultaneously with high sensitivity and precision. The company’s technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. NanoString is also developing the technology for use in molecular diagnostics.

The NanoString Technologies design logo, NanoString, NanoString Technologies and nCounter are registered trademarks of NanoString Technologies, Inc. All other trademarks are property of their respective owners.

For more information, please click here

Contacts:
For NanoString Technologies
Nicole Litchfield
415-793-6468

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

For 2-D boron, it's all about that base: Rice University theorists show flat boron form would depend on metal substrates September 2nd, 2015

Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015

Phagraphene, a 'relative' of graphene, discovered September 2nd, 2015

A marine creature's magic trick explained: Crystal structures on the sea sapphire's back appear differently depending on the angle of reflection September 2nd, 2015

Products

Nanofilm Introduces Clarity AR Lens Cleaner for Anti-Reflective Superhydrophobic Lenses August 20th, 2015

Pixelligent Launches New PixClear® Light Extraction Materials for OLED Lighting August 4th, 2015

Aculon Launches NanoProof Series for PCB Waterproofing July 20th, 2015

Philips Introduces Quantum Dot TV with Color IQ™ Technology from QD Vision: Manufacturer is first to offer quantum dot displays for both TVs and monitors June 30th, 2015

Govt.-Legislation/Regulation/Funding/Policy

For 2-D boron, it's all about that base: Rice University theorists show flat boron form would depend on metal substrates September 2nd, 2015

Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015

A marine creature's magic trick explained: Crystal structures on the sea sapphire's back appear differently depending on the angle of reflection September 2nd, 2015

Sustainable nanotechnology center September 1st, 2015

Nanomedicine

Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015

Using DNA origami to build nanodevices of the future September 1st, 2015

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Announcements

For 2-D boron, it's all about that base: Rice University theorists show flat boron form would depend on metal substrates September 2nd, 2015

Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015

Phagraphene, a 'relative' of graphene, discovered September 2nd, 2015

A marine creature's magic trick explained: Crystal structures on the sea sapphire's back appear differently depending on the angle of reflection September 2nd, 2015

Tools

Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015

Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015

50 Years of Scanning Electron Microscopy from ZEISS: ZEISS celebrates the birth of the first commercial scanning electron microscope in 1965 August 26th, 2015

Announcing Oxford Instruments and School of Physics signing a Memorandum of Understanding August 26th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic